Development of epigenetic hybrid inhibitors targeting angiogenesis and tumor progression by inducing synergistic cytotoxicity in solid tumors

Abstract

newline

Description

Keywords

Citation

item.page.endorsement

item.page.review

item.page.supplemented

item.page.referenced